Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia

• Main Authors: Yu-An Chen (Author), Ying-Ju Lin (Author), Cheng-Li Lin (Author), Hwai-Jeng Lin (Author), Hua-Shan Wu (Author), Hui-Ying Hsu (Author), Yu-Chen Sun (Author), Hui-Yu Wu (Author), Chih-Ho Lai (Author), Chia-Hung Kao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2018-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Prostate cancer (PCa) is one of the most commonly diagnosed cancers in the western world, and the mortality rate from PCa in Asia has been increasing recently. Statins are potent inhibitors of 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase and are commonly used for treating hyperlipidemi...